供体来源的游离DNA可能证实肾移植受者急性排斥反应治疗的实时反应。 - Suppr

Suppr

超能文献

Donor-derived Cell-free DNA May Confirm Real-time Response to Treatment of Acute Rejection in Renal Transplant Recipients.

作者信息

Hinojosa Randall J, Chaffin Kim, Gillespie Matthew, Villarreal V Herman

机构信息

CHRISTUS Transplant Institute, San Antonio, TX.

CareDx, Inc., Brisbane, CA.

出版信息

Transplantation. 2019 Apr;103(4):e61. doi: 10.1097/TP.0000000000002579.

DOI:10.1097/TP.0000000000002579

PMID:30747838

Abstract

摘要

相似文献

Donor-derived Cell-free DNA May Confirm Real-time Response to Treatment of Acute Rejection in Renal Transplant Recipients.供体来源的游离DNA可能证实肾移植受者急性排斥反应治疗的实时反应。

Transplantation. 2019 Apr;103(4):e61. doi: 10.1097/TP.0000000000002579.

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.供者游离 DNA 可在纳武利尤单抗治疗期间检测肾移植排斥反应。

J Immunother Cancer. 2019 Jul 12;7(1):182. doi: 10.1186/s40425-019-0653-6.

The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.使用血浆供体来源的无细胞 DNA 监测肾移植后的急性排斥反应。

Nephrol Dial Transplant. 2020 Apr 1;35(4):714-721. doi: 10.1093/ndt/gfz091.

Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNA.发生急性排斥反应的再次肾移植受者体内供体来源的游离DNA水平升高。

Am J Transplant. 2019 May;19(5):1597-1598. doi: 10.1111/ajt.15192. Epub 2018 Dec 10.

Donor-Derived Cell-Free DNA (ddcf-DNA) and Acute Antibody-Mediated Rejection in Kidney Transplantation.供体来源的无细胞 DNA（ddcf-DNA）与肾移植中的急性抗体介导排斥反应。

Medicina (Kaunas). 2021 May 1;57(5):436. doi: 10.3390/medicina57050436.

Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study.肾移植术后早期血浆 ddcfDNA 水平的动态变化：一项单中心的初步研究。

Transpl Int. 2019 Feb;32(2):184-192. doi: 10.1111/tri.13341. Epub 2018 Oct 2.

Donor Derived Cell Free DNA in Kidney Transplantation: The Circa 2020-2021 Update.供体游离 DNA 在肾移植中的应用：2020-2021 年进展。

Transpl Int. 2022 Jun 1;35:10448. doi: 10.3389/ti.2022.10448. eCollection 2022.

A comparison of two different analytical methods for donor-derived cell-free DNA quantification.两种不同分析方法用于供体来源游离DNA定量的比较。

Clin Biochem. 2021 Oct;96:82-84. doi: 10.1016/j.clinbiochem.2021.07.005. Epub 2021 Jul 7.

The role of donor-derived cell-free DNA in the detection of renal allograft injury.供者游离 DNA 在肾移植损伤检测中的作用。

Nephrol Ther. 2021 Feb;17(1):12-17. doi: 10.1016/j.nephro.2020.10.003. Epub 2021 Jan 14.

Donor-derived Cell-free DNA for the Diagnosis of Kidney Transplant Rejection: An Attractive Test With Ambiguous Answers!供体来源的游离DNA用于肾移植排斥反应的诊断：一项答案模糊但颇具吸引力的检测！

Transplantation. 2021 Jun 1;105(6):1171-1172. doi: 10.1097/TP.0000000000003696.

引用本文的文献

Graft-derived cell free DNA: used for assessment of early graft status and its implications for long-term kidney function.移植来源的游离DNA：用于评估早期移植状态及其对长期肾功能的影响。

Front Physiol. 2024 Nov 15;15:1440799. doi: 10.3389/fphys.2024.1440799. eCollection 2024.

Clinical Value of Peripheral Blood Gene Expression Profile and Donor-Derived Cellfree DNA for Identifying Persistent Rejection.外周血基因表达谱和供体来源游离DNA在识别持续性排斥反应中的临床价值

Kidney360. 2024 Oct 1;5(10):1534-1542. doi: 10.34067/KID.0000000000000549. Epub 2024 Aug 14.

Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation.分析影响肾移植中供体游离 DNA 检测的主要因素。

Front Immunol. 2024 Sep 6;15:1435578. doi: 10.3389/fimmu.2024.1435578. eCollection 2024.

Perspective for Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection After Kidney Transplantation: Defining Context of Use and Clinical Implications.供体来源无细胞 DNA 在肾移植后抗体介导排斥反应中的作用：定义使用范围和临床意义。

Transpl Int. 2024 Aug 12;37:13239. doi: 10.3389/ti.2024.13239. eCollection 2024.

Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.供者来源的无细胞 DNA（dd-cfDNA）在有指征性肾移植活检结果的受者中的应用：一项前瞻性单中心试验的结果。

Transpl Int. 2023 Nov 3;36:11899. doi: 10.3389/ti.2023.11899. eCollection 2023.

Molecular monitoring of lung allograft health: is it ready for routine clinical use?肺移植后健康的分子监测：是否已准备好常规临床应用？

Eur Respir Rev. 2023 Nov 22;32(170). doi: 10.1183/16000617.0125-2023. Print 2023 Dec 31.

Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ Transplantation.游离核酸作为实体器官移植受者的生物标志物。

Ann Transplant. 2023 Aug 15;28:e939750. doi: 10.12659/AOT.939750.

The Trend of Serum Creatinine Does Not Predict Follow-Up Biopsy Findings Among Kidney Transplant Recipients With Antibody-Mediated Rejection.血清肌酐水平的变化趋势并不能预测抗体介导排斥反应的肾移植受者的随访活检结果。

Transplant Direct. 2023 May 24;9(6):e1489. doi: 10.1097/TXD.0000000000001489. eCollection 2023 Jun.

The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation.肾移植中供体来源游离DNA在同种异体移植监测中的应用现状

J Pers Med. 2022 Oct 12;12(10):1700. doi: 10.3390/jpm12101700.

Donor-derived Cell-free DNA Complements De Novo Class II DSA in Detecting Late Alloimmune Injury Post Kidney Transplantation.供体来源的游离DNA在检测肾移植后晚期同种免疫损伤中补充了新生的Ⅱ类供者特异性抗体。

Transplant Direct. 2022 Jan 26;8(2):e1285. doi: 10.1097/TXD.0000000000001285. eCollection 2022 Feb.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验